other material
confidence high
sentiment negative
materiality 0.70
Shuttle Pharmaceuticals implements 70% salary reduction for all salaried employees, including named executive officers
Shuttle Pharmaceuticals Holdings, Inc.
- Effective May 21, 2025, all salaried employees and named executive officers face a 70% salary reduction.
- Affected executives: Interim CEO Christopher Cooper, COO Peter Dritschilo, CSO Mira Jung, CCO Tyvin Rich, VP Regulatory Michael P. Vander Hoek.
- CFO Timothy Lorber's 70% salary reduction is deferred and will be paid later, unlike the outright reduction for others.
- The salary cuts reflect a significant cost-reduction measure amid apparent financial pressures.